The present invention encompasses compounds of general formula (1) where in the groups R
0
to R
3
and L are defined as in claim
1
, which are suitable for the 5 treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain compounds of this kind and their use as medicaments.